MergerJun 10, 2026, 05:36 PM
Aditxt Subsidiary Ignite Proteomics to Become Independent Public Company for $150M
AI Summary
Aditxt, Inc. announced that its wholly-owned subsidiary, Ignite Proteomics, LLC, has entered into a definitive Business Combination Agreement with Copley Acquisition Corp. This agreement will result in Ignite Proteomics becoming an independent, publicly traded company on the NYSE, valued at approximately $150 million. Aditxt will continue to operate as a separate entity listed on the Nasdaq. The transaction involves a SPAC merger and a company merger, with Ignite's equity holders receiving Pubco Common Stock valued at $150 million, and Copley Acquisition Sponsors Limited receiving $4 million.
Key Highlights
- Aditxt, Inc. (ADTX) and its subsidiary Ignite Proteomics, LLC have entered into a Business Combination Agreement with Copley Acquisition Corp.
- The transaction values Ignite Proteomics at approximately $150 million.
- Ignite Proteomics will become an independent, publicly traded company listed on the NYSE.
- Aditxt will continue to operate as a separate Nasdaq-listed company.
- The aggregate consideration to Ignite's equity holders is $150 million in Pubco Common Stock, based on a $10.00 per share reference price.
- Copley Acquisition Sponsors Limited will receive $4,000,000.
Price Impact
More from ADTX